Resectable Borderline Pancreatic Adenocarcinoma clinical trials

Explore recruiting resectable borderline pancreatic adenocarcinoma clinical trials.

Recruiting resectable borderline pancreatic adenocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Resectable Borderline Pancreatic Adenocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PRODIGE 104 – NEOPREDICT A multicenter phase II trial using transcriptomic signatures to personalize neoadjuvant chemotherapy for patients with resectable borderline pancreatic adenocarcinoma.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Resectable Borderline Pancreatic Adenocarcinoma trials by city

Resectable Borderline Pancreatic Adenocarcinoma in Toronto Resectable Borderline Pancreatic Adenocarcinoma in Vancouver Resectable Borderline Pancreatic Adenocarcinoma in Montreal Resectable Borderline Pancreatic Adenocarcinoma in Calgary Resectable Borderline Pancreatic Adenocarcinoma in Edmonton Resectable Borderline Pancreatic Adenocarcinoma in Ottawa Resectable Borderline Pancreatic Adenocarcinoma in Winnipeg Resectable Borderline Pancreatic Adenocarcinoma in Quebec City Resectable Borderline Pancreatic Adenocarcinoma in Hamilton Resectable Borderline Pancreatic Adenocarcinoma in Kitchener Resectable Borderline Pancreatic Adenocarcinoma in London Resectable Borderline Pancreatic Adenocarcinoma in Halifax Resectable Borderline Pancreatic Adenocarcinoma in New York Resectable Borderline Pancreatic Adenocarcinoma in Los Angeles Resectable Borderline Pancreatic Adenocarcinoma in Chicago Resectable Borderline Pancreatic Adenocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease